What's New on the FDA Drugs Site
January 9, 2017
- Annual Reporting by Prescription Drug Wholesale Distributors and Third-Party Logistics Providers: Questions and Answers Guidance for Industry (PDF - 112KB)
- Drug Firm Annual Registration Status Download File (updated)
- Drug Firm Annual Registration Status (updated)
- FDA Drug Shortages
- Atropine Sulfate Injection (Updated - Currently in Shortage)
- Calcium Chloride Injection, USP (Updated - Currently in Shortage)
- Cefepime Injection (Updated - Currently in Shortage)
- Fentanyl Citrate (Sublimaze) Injection (Updated - Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated - Currently in Shortage)
- Multi-Vitamin Infusion (Adult and Pediatric) (Updated - Currently in Shortage)
- Piperacillin and Tazobactam (Zosyn) Injection (Updated - Currently in Shortage)
- Potassium Chloride Injection (Updated - Currently in Shortage)
- Impact of Exclusivity on Approval of Arymo ER
- National Drug Code Directory
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
January 6, 2017
- Drug Firm Annual Registration Status Download File (updated)
- Drug Firm Annual Registration Status (updated)
- FDA Drug Shortages
- Ranitidine Injection, USP (Updated - Currently in Shortage)
- National Drug Code Directory
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
- Office of Prescription Drug Promotion (OPDP) Research
- Consumer and Healthcare Professional Identification of and Responses to Deceptive Prescription Drug Advertising (Updated - Federal Register Notice)
.png)
No hay comentarios:
Publicar un comentario